FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Actonel Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
ACTONEL is indicated for the treatment and prevention of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, ACTONEL reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see Clinical Studies (14.1, 14.2)].
ACTONEL is indicated for treatment to increase bone mass in men with osteoporosis.
ACTONEL is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of ≥ 7.5 mg prednisone or equivalent) for chronic diseases. Patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin D.
ACTONEL is indicated for treatment of Paget’s disease of bone in men and women.
History
There is currently no drug history available for this drug.
Other Information
ACTONEL (risedronate sodium) tablets is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each ACTONEL tablet for oral administration contains the equivalent of 5, 30, 35, 75, or 150 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium hemi-pentahydrate is C7H10NO7P2Na •2.5 H2O. The chemical name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. The chemical structure of risedronate sodium hemi-pentahydrate is the following:
Risedronate sodium is a fine, white to off-white, odorless, crystalline powder. It is soluble in water and in aqueous solutions, and essentially insoluble in common organic solvents.
Inactive Ingredients
All dose strengths contain: crospovidone, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, titanium dioxide.
Dose strength-specific ingredients include: 5 mg—ferric oxide yellow, lactose monohydrate; 30 mg—lactose monohydrate; 35 mg—ferric oxide red, ferric oxide yellow, lactose monohydrate; 75 mg—ferric oxide red; 150 mg—FD&C blue #2 aluminum lake.
Sources
Actonel Manufacturers
-
Warner Chilcott Pharmaceuticals Inc.
Actonel | Warner Chilcott Pharmaceuticals Inc.
ACTONEL should be taken at least 30 minutes before the first food or drink of the day other than water.
To facilitate delivery to the stomach, ACTONEL should be swallowed while the patient is in an upright position and with a full glass of plain water (6 to 8 oz). Patients should not lie down for 30 minutes after taking the medication [see Warnings and Precautions (5.1)].
Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate [see Warnings and Precautions (5.2)]. Calcium supplements and calcium-, aluminum-, and magnesium-containing medications may interfere with the absorption of ACTONEL and should be taken at a different time of the day. ACTONEL is not recommended for use in patients with severe renal impairment (creatinine clearance <30 mL/min). No dosage adjustment is necessary in patients with a creatinine clearance ≥30 mL/min or in the elderly.
2.1 Treatment of Postmenopausal Osteoporosis[see Indications and Usage (1.1)]
The recommended regimen is:
one 5 mg tablet orally, taken dailyor
one 35 mg tablet orally, taken once a weekor
one 75 mg tablet orally, taken on two consecutive days for a total of two tablets each monthor
one 150 mg tablet orally, taken once a month 2.2 Prevention of Postmenopausal Osteoporosis[see Indications and Usage (1.1)]
The recommended regimen is:
one 5 mg tablet orally, taken dailyor
one 35 mg tablet orally, taken once a weekor
alternatively, one 75 mg tablet orally, taken on two consecutive days for a total of two tablets each month may be consideredor
alternatively, one 150 mg tablet orally, taken once a month may be considered 2.3 Treatment to Increase Bone Mass in Men with Osteoporosis[see Indications and Usage (1.2)]
The recommended regimen is:
one 35 mg tablet orally, taken once a week 2.4 Treatment and Prevention of Glucocorticoid-Induced Osteoporosis[see Indications and Usage (1.3)]
The recommended regimen is:
one 5 mg tablet orally, taken daily 2.5 Treatment of Paget’s Disease[see Indications and Usage (1.4)]
The recommended treatment regimen is 30 mg orally once daily for 2 months. Retreatment may be considered (following post-treatment observation of at least 2 months) if relapse occurs, or if treatment fails to normalize serum alkaline phosphatase. For retreatment, the dose and duration of therapy are the same as for initial treatment. No data are available on more than 1 course of retreatment.
-
Physicians Total Care, Inc.
Actonel | Physicians Total Care, Inc.
ACTONEL should be taken at least 30 minutes before the first food or drink of the day other than water.
To facilitate delivery to the stomach, ACTONEL should be swallowed while the patient is in an upright position and with a full glass of plain water (6 to 8 oz). Patients should not lie down for 30 minutes after taking the medication [see Warnings and Precautions (5.1)].
Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate [see Warnings and Precautions (5.2)]. Calcium supplements and calcium-, aluminum-, and magnesium-containing medications may interfere with the absorption of ACTONEL and should be taken at a different time of the day. ACTONEL is not recommended for use in patients with severe renal impairment (creatinine clearance <30 mL/min). No dosage adjustment is necessary in patients with a creatinine clearance ≥30 mL/min or in the elderly.
2.1 Treatment of Postmenopausal Osteoporosis[see Indications and Usage (1.1)]
The recommended regimen is:
one 5 mg tablet orally, taken dailyor
one 35 mg tablet orally, taken once a weekor
one 75 mg tablet orally, taken on two consecutive days for a total of two tablets each monthor
one 150 mg tablet orally, taken once a month 2.2 Prevention of Postmenopausal Osteoporosis[see Indications and Usage (1.1)]
The recommended regimen is:
one 5 mg tablet orally, taken dailyor
one 35 mg tablet orally, taken once a weekor
alternatively, one 75 mg tablet orally, taken on two consecutive days for a total of two tablets each month may be consideredor
alternatively, one 150 mg tablet orally, taken once a month may be considered 2.3 Treatment to Increase Bone Mass in Men with Osteoporosis[see Indications and Usage (1.2)]
The recommended regimen is:
one 35 mg tablet orally, taken once a week 2.4 Treatment and Prevention of Glucocorticoid-Induced Osteoporosis[see Indications and Usage (1.3)]
The recommended regimen is:
one 5 mg tablet orally, taken daily 2.5 Treatment of Paget’s Disease[see Indications and Usage (1.4)]
The recommended treatment regimen is 30 mg orally once daily for 2 months. Retreatment may be considered (following post-treatment observation of at least 2 months) if relapse occurs, or if treatment fails to normalize serum alkaline phosphatase. For retreatment, the dose and duration of therapy are the same as for initial treatment. No data are available on more than 1 course of retreatment.
-
Warner Chilcott (Us), Llc
Actonel | Warner Chilcott (us), Llc
2.1 Treatment of Postmenopausal Osteoporosis[see Indications and Usage (1.1)]
The recommended regimen is:
one 5 mg tablet orally, taken daily
or one 35 mg tablet orally, taken once-a-week
or one 75 mg tablet orally, taken on two consecutive days for a total of two tablets each month
or one 150 mg tablet orally, taken once-a-month 2.2 Prevention of Postmenopausal Osteoporosis[see Indications and Usage (1.1)]
The recommended regimen is:
one 5 mg tablet orally, taken daily
or one 35 mg tablet orally, taken once-a-week
or alternatively, one 75 mg tablet orally, taken on two consecutive days for a total of two tablets each month may be considered
or alternatively, one 150 mg tablet orally, taken once-a-month may be considered 2.3 Treatment to Increase Bone Mass in Men with Osteoporosis[see Indications and Usage (1.2)]
The recommended regimen is:
one 35 mg tablet orally, taken once-a-week 2.4 Treatment and Prevention of Glucocorticoid-Induced Osteoporosis[see Indications and Usage (1.3)]
The recommended regimen is:
one 5 mg tablet orally, taken daily 2.5 Treatment of Paget’s Disease[see Indications and Usage (1.4)]
The recommended treatment regimen is 30 mg orally once daily for 2 months. Retreatment may be considered (following post-treatment observation of at least 2 months) if relapse occurs, or if treatment fails to normalize serum alkaline phosphatase. For retreatment, the dose and duration of therapy are the same as for initial treatment. No data are available on more than 1 course of retreatment.
2.6 Important Administration InstructionsInstruct patients to do the following:
Take ACTONEL at least 30 minutes before the first food or drink of the day other than water, and before taking any oral medication or supplementation, including calcium, antacids, or vitamins to maximize absorption and clinical benefit, [see Drug Interactions (7.1)]. Avoid the use of water with supplements, including mineral water, because they may have a higher concentration of calcium. Swallow ACTONEL tablets whole with a full glass of plain water (6 to 8 ounces). Avoid lying down for 30 minutes after taking the medication [see Warnings and Precautions (5.1)]. Do not chew or suck the tablet because of a potential for oropharyngeal ulceration. Do not eat or drink anything except plain water, or take other medications for at least 30 minutes after taking ACTONEL. 2.7 Recommendations for Calcium and Vitamin D SupplementationInstruct patients to take supplemental calcium and vitamin D if their dietary intake is inadequate; and to take calcium supplements, antacids, magnesium-based supplements or laxatives, and iron preparations at a different time of the day as they interfere with the absorption of ACTONEL.
2.8 Administration Instructions for Missed DosesInstruct patients about missing ACTONEL doses as follows:
If a dose of ACTONEL 35 mg once-a-week is missed: Take 1 tablet on the morning after they remember and return to taking 1 tablet once-a-week, as originally scheduled on their chosen day. Do not take 2 tablets on the same day. If one or both tablets of ACTONEL 75 mg on two consecutive days per month are missed, and the next month’s scheduled doses are more than 7 days away: If both tablets are missed, take one ACTONEL 75 mg tablet in the morning after the day it is remembered and then the other tablet on the next consecutive morning. If only one ACTONEL 75 mg tablet is missed, take the missed tablet in the morning after the day it is remembered Return to taking their ACTONEL 75 mg on two consecutive days per month as originally scheduled. Do not take more than two 75 mg tablets within 7 days. If one or both tablets of ACTONEL 75 mg on two consecutive days per month are missed, and the next month's scheduled doses are within 7 days: Wait until their next month’s scheduled doses and then continue taking ACTONEL 75 mg on two consecutive days per month as originally scheduled. If the dose of ACTONEL 150 mg once-a-month is missed, and the next month’s scheduled dose is more than 7 days away: Take the missed tablet in the morning after the day it is remembered and then return to taking their ACTONEL 150 mg once-a-month as originally scheduled. Do not take more than one 150 mg tablet within 7 days. If the dose of ACTONEL 150 mg once-a-month is missed, and the next month's scheduled dose is within 7 days: Wait until their next month’s scheduled dose and then continue taking ACTONEL 150 mg once-a-month as originally scheduled.
Login To Your Free Account